MedTrace Logo

Anti-Mullerian Hormone Levels Before and After an Open Myomectomy

NCT01723085 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2018-07-30

No results posted yet for this study

Summary

Anti-Mullerian hormone (AMH) is a marker for ovarian reserve. It is well known that ovarian surgery for endometriosis lowers Anti-Mullerian hormone, but little is known for other surgeries. We seek to investigate the hormone variations before and after an open myomectomy.

Hypothesis: Anti-Mullerian hormone levels drop following surgery but return to normal levels in a few months

Conditions

  • Anti-Mullerian Hormone

Sponsors & Collaborators

  • Clinique Ovo

    lead INDUSTRY

Principal Investigators

  • Eric Himaya, MD · Centre hospitalier de l'Université de Montréal (CHUM)

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01723085 on ClinicalTrials.gov